Microbiological models as screening tools for anticancer agents: potentials and limitations.
D000964:Antimetabolites, Antineoplastic / Q000032:analysis; D000970:Antineoplastic Agents / Q000032:analysis / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000235:genetics; D001435:Bacteriophages / Q000187:drug effects / Q000235:genetics; D002463:Cell Membrane Permeability; D004260:DNA Repair; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D005144:F Factor; D008242:Lysogeny / Q000187:drug effects; D009154:Mutation / Q000187:drug effects; D010941:Plant Tumors; D013768:Tetrahymena / Q000502:physiology; D014775:Virus Activation / Q000187:drug effects; D014780:Viruses / Q000187:drug effects*; D015003:Yeasts / Q000187:drug effects* / Q000378:metabolism
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents